Position in GH
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$25,354
+$12,608 QoQ
Shares Held
169
+22.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#497
of 594 holders
Holding Since
Sep 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026BESSEMER GROUP INC holds $607,176,812 across 24 Diagnostics & Research names. GH ranks #19 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LH |
Labcorp Holdings Inc.
|
675,634 | $189,177,520 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
288,814 | $152,043,237 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
282,897 | $149,819,415 | |
| 4 | A |
Agilent Technologies, Inc.
|
394,540 | $52,406,743 | |
| 5 | RDNT |
RadNet, Inc.
|
397,383 | $24,504,324 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
|
28,431 | $14,254,162 | |
| 7 | DHR |
Danaher Corp /De/
|
36,489 | $6,949,850 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
22,952 | $5,205,281 |
All Filings in GH
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,354 | 169 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $12,746 | 138 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $5,107 | 50 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $3,124 | 50 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $3 | 50 | Shares | Defined | 2025-08-01 | |
| 2025-03-31 | $2,130 | 50 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $2 | 55 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1 | 55 | Shares | Defined | 2024-11-12 | |
| 2023-03-31 | $1 | 56 | Shares | Defined | 2023-05-10 | |
| 2021-09-30 | $19,751 | 158 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||